MetLife Investment Management’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-22,286
| Closed | -$96.9K | – | 2817 |
|
|
2024
Q3 | $96.9K | Buy |
22,286
+12,557
| +129% | +$54.6K | ﹤0.01% | 2641 |
|
|
2024
Q2 | $45.3K | Buy |
+9,729
| New | +$45.3K | ﹤0.01% | 2771 |
|
|
2021
Q2 | – | Sell |
-8,148
| Closed | -$198K | – | 2441 |
|
|
2021
Q1 | $198K | Hold |
8,148
| – | – | ﹤0.01% | 2056 |
|
|
2020
Q4 | $261K | Hold |
8,148
| – | – | ﹤0.01% | 1836 |
|
|
2020
Q3 | $246K | Buy |
8,148
+1,831
| +29% | +$55.4K | ﹤0.01% | 1731 |
|
|
2020
Q2 | $266K | Hold |
6,317
| – | – | ﹤0.01% | 1729 |
|
|
2020
Q1 | $158K | Buy |
+6,317
| New | +$158K | ﹤0.01% | 1825 |
|